Samsung Biologics
207940.KS
#346
Rank
$45.14 B
Marketcap
$631.24
Share price
-2.53%
Change (1 day)
-15.92%
Change (1 year)

Revenue for Samsung Biologics (207940.KS)

Revenue in 2022 (TTM): $1.53 B

According to Samsung Biologics 's latest financial reports the company's current revenue (TTM) is $1.53 B. In 2021 the company made a revenue of $1.34 B an increase over the years 2020 revenue that were of $1.00 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Samsung Biologics from 2016 to 2022

Annual revenue

Year Revenue Change
2022 (TTM)$1.53 B14.25%
2021$1.34 B33.88%
2020$1.00 B67.07%
2019$0.60 B23.77%
2018$0.48 B16.23%
2017$0.41 B64.54%
2016$0.25 B